Study offers real-world data on commercial implementation of gene therapies for sickle cell disease, beta thalassemia

A study assessing the real-world commercial roll-out of gene therapies for sickle cell disease and beta thalassemia offers lessons learned to inform best practices as manufacturers and medical centers prepare to meet growing demand for gene…

Continue Reading

News Source: medicalxpress.com